Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 138 publications
Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group.
Journal: Nature reviews. Urology
Published: July 22, 2026
Durable Responses and Cystectomy Avoidance with IL-15 Receptor Agonist NAI plus BCG In BCG-Unresponsive NMIBC with Carcinoma In Situ +/- Papillary Disease.
Journal: The Journal of urology
Published: July 06, 2026
Early Efficacy and Exploratory Biomarker Data of Bel-sar in Patients with Intermediate-risk and High-risk Non-muscle-invasive Bladder Cancer.
Journal: European urology open science
Published: May 20, 2026
Clinical Trial Design for Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer-Single-Arm Design Was Necessary, Randomized Trials Are Now Essential.
Journal: The Journal of urology
Published: January 30, 2026
Clinical trials corner issue 12(1).
Journal: Bladder cancer (Amsterdam, Netherlands)
Published: January 23, 2026
Transfer and beyond: emerging strategies and trends in two-dimensional material device fabrication.
Journal: Chemical Society reviews
Published: January 06, 2026
Prolonged Progression-Free Survival, Disease-Free Survival, and Cystectomy Avoidance With IL-15 Receptor Lymphocyte-Stimulating Agent NAI Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin-Unresponsive Papillary-Only Nonmuscle-Invasive Bladder Cancer.
Journal: The Journal of urology
Published: September 16, 2025
Outcomes of Reinduction With Nadofaragene Firadenovec.
Journal: The Journal of urology
Published: August 25, 2025
Last Updated: 09/26/2026